GLP-1s Tied to Lower Rates of MS Relapse Activity, Real-World Study Shows
(MedPage Today) -- Multiple sclerosis (MS) patients exposed to a GLP-1 receptor agonist had lower rates of relapse activity and steroid use, reduced incidence of optic neuritis, and fewer demyelinating events compared with those who didn't use...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.